SYROS PHARMACEUTICALS INC

CUSIP: 87184Q107 Class: COM

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 16,466 Value ($000) $16 Avg Close Range
Q1 2022
Shares 137,156 Value ($000) $163 Avg Close Range
Q4 2021
Shares 118,632 Value ($000) $387 Avg Close Range
Q3 2021
Shares 103,307 Value ($000) $462 Avg Close Range
Q2 2021
Shares 76,052 Value ($000) $414 Avg Close Range
Q2 2019
Shares 28,838 Value ($000) $267 Avg Close Range
Q1 2019
Shares 118,861 Value ($000) $1,086 Avg Close Range
Q4 2018
Shares 122,561 Value ($000) $683 Avg Close Range
Q3 2018
Shares 118,661 Value ($000) $1,413 Avg Close Range
Q2 2018
Shares 102,661 Value ($000) $1,048 Avg Close Range
Q1 2018
Shares 57,311 Value ($000) $744 Avg Close Range
Q4 2017
Shares 14,611 Value ($000) $142 Avg Close Range